Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: E'Lane who wrote (14417)	8/29/1998 12:03:00 PM
From: jack w garnes jr.	Read Replies (1) \| Respond to of 23519

E'Lane, I agree VLAD has been a asset to this thread. But I do think he needs to relax. I try to kid with him...but most of the time he is all business... Some times you just have to forget about a bad investment for a while... JG

To: E'Lane who wrote (14417)	8/29/1998 12:13:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

<<Go back 6 months and see who all is NOT posting and putting up with this nonsense.>> mm? Hmmmmm, okay i read the tea leaves as well as anyone else. Decided to come out of lurk mode since Frosty showed up anyways:) It takes 350+ million to get a new drug approved and on the market. Forget the manufacturing plants, equipment, and pipeline drugs. The current market cap of VVUS is about 120 million dollars now. Its oversold, IMO. One of he reasons i thought back in December that 10 to 13 was a good buy range was because it does take 350+ million to bring a drug to market. 350 million dollars divided by 30 million outstanding shares is a share price of 11 dollars. I thought 10 was the floor, with maybe 8 being seen in an extreme selloff. 3 7/8???? i never thought this possible. The valuation is out of whack here. For whatever reason, its not a reflection of the company's true market value. Even domestically, MUSE sells every week. The IMS numbers are only a reflection of 60% of total scripts written. And MUSE sells, even in the face of a poor marketing job by the management. This product has a niche, and in a worldwide marketplace, this company will be profitable. VLAD, feel bad about your margin exposure. Hang in there.